LEUKO REAGENT REQUIREMENTS FOR OKINAWA, JAPAN SPE8EQ-25-R-Q005
Summary
AI-generated · Sep 16, 2025Leukocyte reagent requirements for Okinawa, Japan. This is a Combined Synopsis/Solicitation.
The description field is empty, so the exact scope, quantities, performance standards, delivery terms, and bid requirements are not provided here. Bidders should review the official posting for the complete description to learn the precise reagents requested, any qualification or certification requirements, and the submission deadlines.
Dear Valued Suppliers, DLA TROOP SUPPORT INDO-PACIFIC is issuing a solicitation intending to ultimately enter into a Simplified Indefinite-Delivery Contract ( SIDC ) with a commercial firm in fulfilling a requirement for the procurement and delivery of CLASS VIII, Medical Leuko Reagents, in support of United States Naval Hospital (USNH), located in Okinawa, Japan. These reagents are critical supply items that enable the department to perform essential analysis for the purposes of physician diagnosis, treatment, and care of active duty, family members and other eligible beneficiaries assigned to U.S. Forces. All supplies required are listed on the attached Item Descriptions Delivery Schedules FY26 - FY28 (Schedule of Items). Submissions: Please see all attachments. If interested, we strongly encourage submitting all completed documents required (i.e. signed copy of SF1449 cover letter, prices for all items for both the basic period & two (2) one-year option periods, required certificates, etc.). We appreciate and thank you in advance for your quote. Your responses regarding this solicitation are requested back by 29 SEP 2025 at 15:00 pm JST. Please respond via email to the following address: eric.guidish@dla.mil.
From Combined Synopsis/Solicitation posted on Sep 14, 2025Notice history
1-
Combined Synopsis/Solicitation LATEST Posted Sep 14, 2025
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
JPN